636 A phase 1, open-label, dose escalation and expansion study of CUE-102 monotherapy in HLA-A*0201 positive patients with WT1-positive recurrent/metastatic cancers

Authors :: Steven Margossian
John Powderly
Nashat Gabrail
Yvonne Saenger
J Eva Selfridge
Nataliya Uboha
Jun Gong
Brian Van Tine
Olatunji Alese
Dae Won Kim
Wen Ma
Tanios Bekaii-Saab
Jeremy Jones
Angela Alistar
Laura Agensky
Apollina Goel
Reena Lynam
Raymond Moniz
Steve Quayle
Cynthia Rajan
Kenneth Pienta
Matteo Levisetti
Source :: Regular and Young Investigator Award Abstracts.
Publication Year :: 2022
Publisher :: BMJ Publishing Group Ltd, 2022.

Full Text Access

Tools